Surgical Outcomes of Total Anomalous Pulmonary Venous Connection Repair

Medicina (Kaunas). 2022 May 23;58(5):687. doi: 10.3390/medicina58050687.

Abstract

Background and Objectives: Over the years, surgical repair of total anomalous pulmonary venous connection (TAPVC) outcomes have improved, however, morbidity and mortality still remain significant. This study aims to assess the early and long-term outcomes of surgical treatment of TAPVC children, operated on between 2006 and 2016, in one pediatric center in Poland. Materials and Methods: Diagnostics, surgical treatment, and follow-up data from 83 patients were collected. In addition, survival and risk factor analyses, control echocardiographic, and electrocardiographic examinations were performed. Results: In the analyzed group (n = 83), there were seven hospital deaths (within 30 days after the operation) (8.4%) and nine late deaths (10.8%). The mean follow-up time was 5.5 years, and, for patients who survived, it was 7.1 years. The mean survival time in patients with completed follow-up (n = 70) was 10.3 years; the overall five-year survival rate was 78.4%. Independent mortality risk factors were type I TAPVC, single ventricle physiology, time from admission to operation, intensive care unit stay, postoperative hospital stay, and temporary kidney insufficiency requiring dialysis. Conclusions: The presence of single ventricle physiology and the supracardiac subtype of TAPVC might be negative prognostic factors, while normal heart physiology presents with good post-repair results. This study indicates that cardiac arrhythmias may occur. Morbidity and mortality, related to surgical TAPVC correction, still remain significant.

Keywords: TAPVC; congenital heart disease; pediatric cardiac surgery; total anomalous pulmonary venous connection.

MeSH terms

  • Child
  • Humans
  • Renal Dialysis*
  • Retrospective Studies
  • Scimitar Syndrome* / surgery
  • Treatment Outcome
  • Vascular Surgical Procedures / methods

Grants and funding

This research received no external funding. The study was supported by the hospital’s internal sources (Children’s Memorial Health Institute, internal grant (No. S184/2019)).